USPTO 2015–2025 USPTO PatentsView US Corporation

Varian Medical Systems, Inc.

USPTO PatentsView assignee record - 419 granted patents across 60 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

419
Total patents granted
60
CPC technology areas
21.2
Avg claims per patent
+51%
5-year filing velocity

The verdict

Varian holds 419 US patents across 60 technology areas, rank #1,040 of 50,000 tracked assignees.

#1,040
of 50,000 US assignees by volume
Top 1%
by Innovation Score (66.1/100)
21.2
avg claims per patent
+51%
filing velocity, last 5 yrs

Portfolio overview

Varian Medical Systems, Inc. has been granted 419 US utility patents between 2015 and 2025, placing Varian Medical Systems, Inc. at rank #1,040 across all assignees tracked by PlainPatent. This portfolio spans 60 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.2 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Varian Medical Systems, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Varian sits between GN Hearing A/s (421 patents, rank #1,036) and Agrigenics Inc. (416 patents, rank #1,044) - the closest US assignees by grant volume. The composite Innovation Score of 66.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 252 grants, compared with 167 in the 2015–2019 window, a +51% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Varian Medical Systems, Inc.'s 21.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 60 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Varian Medical Systems, Inc. against peers pursuing similar technology classes.

Who files at Varian's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Varian holds 419 patents at rank #1,040, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Varian

By rank, the assignees closest to #1,040 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Varian's primary technology class.

Varian's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

203040506070 20152016201720182019202020212022202320242025 32
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Varian Medical Systems, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 34 8.1%
2016 43 10.3%
2017 27 6.4%
2018 26 6.2%
2019 37 8.8%
2020 39 9.3%
2021 45 10.7%
2022 31 7.4%
2023 61 14.6%
2024 44 10.5%
2025 32 7.6%

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#1,040

Across all tracked assignees

Innovation Score

66.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Varian Medical Systems, Inc. hold?
Varian Medical Systems, Inc. holds 419 US granted patents filed between 2015 and 2025, spanning 60 technology areas.
What is Varian Medical Systems, Inc.'s Innovation Score?
Varian Medical Systems, Inc. has an Innovation Score of 66.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Varian Medical Systems, Inc. focus on?
Varian Medical Systems, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 296 patents. The company has filed patents in 60 CPC subclasses total.
Is Varian Medical Systems, Inc.'s patent filing rate increasing or decreasing?
Varian Medical Systems, Inc.'s recent filing velocity is +51% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Varian Medical Systems, Inc.'s patents?
Varian Medical Systems, Inc.'s patents average 21.2 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Varian Medical Systems, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Varian's 419 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Varian ranks #1,040 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.